跳至主要内容
临床试验/2025-524874-41-00
2025-524874-41-00招募中2 期

Paediatric sarcoma, hybrid imaging & FAPI – Raising the diagnostic standard for paediatric sarcoma patients combining novel radiotracer FAPI and whole-body PET/MRI

Rigshospitalet1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年11月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
40
试验地点
1
主要终点
The ability of the nuclear medicine physician and the radiologist to accurately detect malignancy in [68Ga]Ga-FAPI-46 WB PET/MRI vs. SOC imaging.

研究概览

简要总结

The aim of the study is to evaluate [68Ga]Ga-FAPI-46 WB PET/MRI as a diagnostic tool to improve tumour lesion evaluation at primary staging, during treatment control and at relapse in paediatric sarcoma patients.

入排标准

年龄范围
0 years 至 17 years(0-17 Years)
接受健康志愿者

入选标准

  • <18 years old
  • Referred for evaluation of any type of sarcoma at the Dept. of Paediatric and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet
  • Participant and/or legal guardian must be able to read and understand the PIS in Danish and/or English to sign the ICF.

排除标准

  • Pregnancy or lactation
  • Not considered able to cooperate to the trial imaging procedures without sedation by the referral department
  • Severe claustrophobia or any other positive outcomes on the MRI safety checklist
  • History of allergic reaction due to compounds similar to the chemical composition of [68Ga]Ga-FAPI-46

研究组 & 干预措施

Fluor-18-FDG, 400 MBq-210 GBq, injektionsvreske Fludeoxyglucose (18F)

Comparator

干预措施: Fluor-18-FDG, 400 MBq-210 GBq, injektionsvreske Fludeoxyglucose (18F) (Drug)

68GA-FAPI-46

Test

干预措施: 68GA-FAPI-46 (Drug)

结局指标

主要结局

The ability of the nuclear medicine physician and the radiologist to accurately detect malignancy in [68Ga]Ga-FAPI-46 WB PET/MRI vs. SOC imaging.

The ability of the nuclear medicine physician and the radiologist to accurately detect malignancy in [68Ga]Ga-FAPI-46 WB PET/MRI vs. SOC imaging.

次要结局

  • Correlation of IHC of the FAP-antigen in tumour lesions and tumour FAP-expression using the radioactive tracer [68Ga]Ga-FAPI-46
  • Evaluation of patient and/or parent(s’) and experiences.
  • Evaluation of the technical feasibility of implementation in clinical practice

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Flemming Littrup Andersen

Scientific

Rigshospitalet

研究点 (1)

Loading locations...

相似试验